Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • A study of the effects of AGMB-129 and midazolam in healthy participants

    Not recruiting

    1 1 1 1
    Investigated drugs:
    Belgium
  • A study to evaluate how JNJ-77242113 is absorbed by the body in healthy participants for the treatment of inflammatory diseases.

    Not recruiting

    1 1 1
    Investigated diseases:
    Belgium
  • Study to evaluate the effects of brexanolone and lorazepam on the nervous system in healthy male participants using magnetic brain stimulation

    Not recruiting

    1 1 1
    Investigated drugs:
    The Netherlands
  • A study to compare how the body absorbs empagliflozin tablets in healthy individuals.

    Not recruiting

    1 1 1 1
    Investigated drugs:
    Portugal
  • A study to evaluate the effect of muvalaplin on reducing major cardiovascular events in adults with high levels of lipoprotein(a) and atherosclerotic cardiovascular disease.

    Not recruiting

    3 1
    Investigated diseases:
    Austria Belgium Czechia Denmark France Germany +8
  • A study to compare the absorption of apixaban capsules and apixaban tablets in healthy volunteers to prevent thrombosis.

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain
  • Comparison of montelukast 10 mg capsules and montelukast 10 mg film-coated tablets in healthy volunteers to evaluate how the medicine is absorbed.

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain
  • Efficacy and Safety Evaluation of Belantamab Mafodotin Versus Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients

    Not recruiting

    3 1 1 1
    Belgium Bulgaria France Germany Greece Hungary +4
  • A study to evaluate how the body processes AZ-3102 in healthy male subjects

    Not recruiting

    1 1 1
    The Netherlands
  • Phase 3 Study of Subcutaneous Pembrolizumab with Hyaluronidase vs. Intravenous Pembrolizumab in Metastatic NSCLC with PD-L1 TPS ≥50%

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany Poland Romania Spain